GL1X · GenesisL1 explorer

UniProt Q86W56

Poly(ADP-ribose) glycohydrolase (Q86W56)

Poly(ADP-ribose) glycohydrolase (UniProt Q86W56), EC 3.2.1.143: 49 experimental structures and 1 predicted model on GenesisL1, 18 ligands bound, 74 pockets. Binding sites, druggability and experiment against prediction (TM-score)…

UniProt
Q86W56
Protein
Poly(ADP-ribose) glycohydrolase
EC
3.2.1.143
Experimental structures
49
Predicted models
1
Ligands
18
Pockets
74 · 17 records with a druggable one

Structures

50 records of Q86W56 in the MolNFT archive: 49 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4A0DStructure of unliganded human PARG catalytic domainx-ray diffractionA——
4A0DStructure of unliganded human parg catalytic domainx-ray diffractionA——
4B1GStructure of unliganded human PARG catalytic domainx-ray diffractionA——
4B1GStructure of unliganded human parg catalytic domainx-ray diffractionA——
4B1HStructure of human PARG catalytic domain in complex with ADP-ribosex-ray diffractionA——
4B1HStructure of human parg catalytic domain in complex with ADP-ribosex-ray diffractionA——
4B1IStructure of human PARG catalytic domain in complex with OA-ADP-HPDx-ray diffractionA——
4B1IStructure of human parg catalytic domain in complex with oa-ADP-hpdx-ray diffractionA——
4B1JStructure of human PARG catalytic domain in complex with ADP-HPDx-ray diffractionA——
4B1JStructure of human parg catalytic domain in complex with ADP-hpdx-ray diffractionA——
5A7RHuman poly(ADP-ribose) glycohydrolase in complex with synthetic dimeric ADP-ribosex-ray diffractionA——
5A7RHuman POLY(ADP-ribose) glycohydrolase in complex with synthetic dimeric ADP-ribosex-ray diffractionA——
5LHBPolyadpribosyl glycosidase in complex with PDD00017262x-ray diffractionA6WJ, SO4—
5LHBPolyadpribosyl glycosidase in complex with PDD00017262x-ray diffractionA6WJ, SO4—
6HH6Human poly(ADP-ribose) glycohydrolase in complex with ADP-HPMx-ray diffractionAA3R, SO4—
6HH6Human POLY(ADP-ribose) glycohydrolase in complex with ADP-hpmx-ray diffractionAA3R, SO4—
6HMKPolyadpribosyl glycohydrolase in complex with PDD00016690x-ray diffractionASO4, 7JC4 (best 0.69)
6HMKPolyadpribosyl glycohydrolase in complex with PDD00016690x-ray diffractionASO4, 7JC—
6HMLPolyadpribosyl glycosidase in complex with PDD00017299x-ray diffractionA73L, SO44 (best 0.61)
6HMLPolyadpribosyl glycosidase in complex with PDD00017299x-ray diffractionA73L, SO4—
6HMMPolyadpribosyl glycohydrolase in complex with PDD00013907x-ray diffractionA7JB, SO4—
6HMNPolyadpribosyl glycosidase in complex with PDD00014909x-ray diffractionA70J, SO46 (best 0.66)
6HMNPolyadpribosyl glycosidase in complex with PDD00014909x-ray diffractionA70J, SO4—
6O9XStructure of human PARG complexed with JA2-4x-ray diffractionAM0S4 (best 0.66)
6O9XStructure of human parg complexed with JA2-4x-ray diffractionAM0S—
6O9YStructure of human PARG complexed with JA2-8x-ray diffractionAM0V5 (best 0.64)
6O9YStructure of human parg complexed with JA2-8x-ray diffractionAM0V—
6OA0Structure of human PARG complexed with JA2-9x-ray diffractionAM1D5 (best 0.66)
6OA0Structure of human parg complexed with JA2-9x-ray diffractionAM1D—
6OA1Structure of human PARG complexed with JA2120x-ray diffractionAM0P5 (best 0.67)
6OA1Structure of human parg complexed with JA2120x-ray diffractionAM0P—
6OA3Structure of human PARG complexed with JA2131x-ray diffractionAM0M5 (best 0.67)
6OA3Structure of human parg complexed with JA2131x-ray diffractionAM0M—
6OAKStructure of human PARG complexed with JA2131x-ray diffractionAM0M4 (best 0.66)
6OAKStructure of human parg complexed with JA2131x-ray diffractionAM0M—
6OALStructure of human PARG complexed with JA2120x-ray diffractionAM0P4 (best 0.68)
6OALStructure of human parg complexed with JA2120x-ray diffractionAM0P—
7KFPStructure of human PARG complexed with PARG-119x-ray diffractionAWD7, SO45 (best 0.65)
7KFPStructure of human parg complexed with parg-119x-ray diffractionAWD7, SO4—
7KG0Structure of human PARG complexed with PARG-131x-ray diffractionAWDA, SO44 (best 0.66)
7KG0Structure of human parg complexed with parg-131x-ray diffractionAWDA, SO4—
7KG1Structure of human PARG complexed with PARG-002x-ray diffractionAWDD, SO45 (best 0.65)
7KG1Structure of human parg complexed with parg-002x-ray diffractionAWDD, SO4—
7KG6Structure of human PARG complexed with PARG-322x-ray diffractionAWDG4 (best 0.66)
7KG6Structure of human parg complexed with parg-322x-ray diffractionAWDG—
7KG7Structure of human PARG complexed with PARG-292x-ray diffractionAWDJ, SO43 (best 0.67)
7KG7Structure of human parg complexed with parg-292x-ray diffractionAWDJ, SO4—
7KG8Structure of human PARG complexed with PARG-061x-ray diffractionAWDM, SO43 (best 0.67)
7KG8Structure of human parg complexed with parg-061x-ray diffractionAWDM, SO4—
Q86W56AlphaFold monomer V2.0 prediction for POLY(ADP-ribose) glycohydrolase (Q86W56)predictedA—4 (best 0.77)

Ligands

  • SO4 · Sulfate ion · in 21 records
  • M0M · (8S)-1,3-dimethyl-8-{[2-(morpholin-4-yl) ethyl]sulfanyl}-6-sulfanylidene-1,3,6,7,8,9-hexahydro-2H-purin-2-one · in 4 records
  • M0P · 1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-3,7-dihydro-1H-purine-2,6-dione · in 4 records
  • 6WJ · 1-(cyclopropylmethyl)-6-[[(1-methylcyclopropyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-3-[(2-methyl-1,3-thiazol-5-yl)methyl]quinazoline-2,4-dione · in 2 records
  • 70J · 3-methyl-6-[[(1-methylcyclopropyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-1-(phenylmethyl)quinazoline-2,4-dione · in 2 records
  • 73L · 1-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-6-[[(1-methylcyclopropyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-3-[(1-methylpyrazol-4-yl)methyl]quinazoline-2,4-dione · in 2 records
  • 7JC · 1-methyl-~{N}-(1-methylcyclopropyl)-3-[(2-methyl-1,3-thiazol-5-yl)methyl]-2,4-bis(oxidanylidene) quinazoline-6-sulfonamide · in 2 records
  • A3R · Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol · in 2 records
  • M0S · 1,3-dimethyl-8-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,9-tetrahydro-2H-purin-2-one · in 2 records
  • M0V · 7-[(2S)-2-hydroxy-3-(morpholin-4-yl)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione · in 2 records
  • M1D · 4-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)butanoic acid · in 2 records
  • WD7 · N-{[2-(1,3-dimethyl-2-oxo-6-sulfanylidene-1,2,3,6-tetrahydro-7H-purin-7-yl) ethyl]carbamoyl}methanesulfonamide · in 2 records
  • WDA · 5-({4-[(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)methyl]phenyl}methyl)pyrimidine-2,4,6(1H, 3H,5H)-trione · in 2 records
  • WDD · 1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]amino}-3,7-dihydro-1H-purine-2,6-dione · in 2 records
  • WDG · 1-{2-[(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]ethyl}piperidine-4-carboxylic acid · in 2 records
  • WDJ · 8-{[2-(1,1-dioxo-1lambda~6~,4-thiazinan-4-yl) ethyl]sulfanyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2, 6-dione · in 2 records
  • WDM · 1,3-dimethyl-8-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-6-sulfanylidene-1,3,6,7-tetrahydro-2H-purin-2-one · in 2 records
  • 7JB · ~{N}-~{tert}-butyl-9,10-bis(oxidanylidene)anthracene-2-sulfonamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.